BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24763359)

  • 1. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor.
    Xue JJ; Chen QY; Kong MY; Zhu CY; Gen ZR; Wang ZL
    Eur J Med Chem; 2014 Jun; 80():1-7. PubMed ID: 24763359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity, attenuation on the absorption of calcium in mitochondria, and catalase activity for manganese complexes of N-substituted di(picolyl)amine.
    Zhou DF; Chen QY; Qi Y; Fu HJ; Li Z; Zhao KD; Gao J
    Inorg Chem; 2011 Aug; 50(15):6929-37. PubMed ID: 21710973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
    Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole conjugated silica and magnetic nanoparticles as inhibitors of HIF.
    Chen QY; Wang ZW; Yang X; Wang L
    Colloids Surf B Biointerfaces; 2014 Feb; 114():158-63. PubMed ID: 24184535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterisation of low valent Mn-complexes as models for Mn-catalases.
    Berggren G; Huang P; Eriksson L; Styring S; Anderlund MF; Thapper A
    Dalton Trans; 2010 Dec; 39(45):11035-44. PubMed ID: 20957239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
    Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
    PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structure, and catalase-like activity of dimanganese(III) complexes of 1,5-bis[(2-hydroxy-5-X-benzyl)(2-pyridylmethyl)amino]pentan-3-ol (X = H, Br, OCH3).
    Biava H; Palopoli C; Duhayon C; Tuchagues JP; Signorella S
    Inorg Chem; 2009 Apr; 48(7):3205-14. PubMed ID: 19271771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective catalytic disproportionation of aqueous H2O2 with di- and mono-nuclear manganese(II) complexes containing pyridine alcohol ligands.
    Zienkiewicz M; Jabłońska-Wawrzycka A; Szlachetko J; Kayser Y; Stadnicka K; Sawka-Dobrowolska W; Jezierska J; Barszcz B; Sá J
    Dalton Trans; 2014 Jun; 43(23):8599-608. PubMed ID: 24406400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and evaluation of five coordinated copper(II) complexes as antibacterial, artificial nuclease, and SOD mimics.
    Patel MN; Gandhi DS; Parmar PA
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(6):445-60. PubMed ID: 22646085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination modes of bridge carboxylates in dinuclear manganese compounds determine their catalase-like activities.
    Jiang X; Liu H; Zheng B; Zhang J
    Dalton Trans; 2009 Oct; (40):8714-23. PubMed ID: 19809747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
    Kolev Y; Uetake H; Takagi Y; Sugihara K
    Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
    Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
    Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.
    Liu LZ; Hu XW; Xia C; He J; Zhou Q; Shi X; Fang J; Jiang BH
    Free Radic Biol Med; 2006 Nov; 41(10):1521-33. PubMed ID: 17045920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of hypoxia-inducible factor (HIF)-1α inhibitors: effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia.
    Nakamura H; Yasui Y; Maruyama M; Minegishi H; Ban HS; Sato S
    Bioorg Med Chem Lett; 2013 Feb; 23(3):806-10. PubMed ID: 23267767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.
    Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L
    Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salen-manganese complexes: sophisticated tools for the analysis of intercellular ROS signaling pathways.
    Ophoven SJ; Bauer G
    Anticancer Res; 2010 Oct; 30(10):3967-79. PubMed ID: 21036710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.